The effectiveness removes a key regulatory hurdle for the de-SPAC merger. Monitor for the filing of a final prospectus (424B3) and the shareholder vote date, which will provide the definitive timeline and pricing. The combined entity's post-merger float and any PIPE financing terms will determine near-term trading dynamics.
Price Chart
Executive Summary
The SEC declared effective the registration statement (File No. 333-294461) for NYB Holdings Ltd, a Singapore-based medicinal chemicals company, and its co-filer RF Acquisition Corp II, a blank-check company. This effectiveness clears the way for a business combination or de-SPAC transaction between the two entities, allowing them to issue securities to complete the merger. The filing is a procedural milestone that removes regulatory uncertainty for the deal's closing timeline, though no pricing or financial terms were disclosed in this notice. The AMPLIFIER cross-filing verdict (effect-ipo-context + effect-shelf-context) supports a modest upward impact, as the effectiveness of both a de-SPAC and a shelf registration in tandem is historically associated with positive outcomes for the combined entity's securities.
Key Facts
- Effectiveness date: July 23, 2026.
- Registration statement File No. 333-294461 for NYB Holdings Ltd and File No. 333-294461-01 for RF Acquisition Corp II.
- NYB Holdings Ltd is classified under SIC 2833 (Medicinal Chemicals & Botanical Products); RF Acquisition Corp II is a blank-check company (SIC 6770).
- Both entities are incorporated in Singapore (State of Incorporation: E9).
- The filing is a Notice of Effectiveness under the Securities Act of 1933, not a pricing or prospectus document.
Financial Impact
No financial figures disclosed in the EFFECT filing. The registration covers securities to be issued in connection with a business combination between NYB Holdings and RF Acquisition Corp II; deal value and terms remain undisclosed.
Risk Factors
- No financial terms or deal valuation disclosed in this filing; the underlying business combination may still face shareholder approval or other closing conditions.
- The blank-check structure (RF Acquisition Corp II) carries inherent risk of deal failure or unfavorable redemption rates.
- Singapore incorporation and operations introduce jurisdictional and currency risks not present in US-based issuers.
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (Primary) | 9999999995-26-002411 |
| Document: 9999999995-26-002411-index.html | 9999999995-26-002411 |
| Document: 9999999995-26-002411.txt | 9999999995-26-002411 |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers